Αποτελέσματα Αναζήτησης
15 Απρ 2024 · The PREDICT tool uses a combination of day 1 and day 5 variables (cardiac device, community- versus health care-associated versus nosocomial infection, and duration of bacteremia) to identify patients most likely to benefit from TEE .
- Forsblom E, Ruotsalainen E, Ollgren J, Järvinen A. Telephone Consultation Cannot Replace Bedside Infectious Disease Consultation in The Management of Staphylococcus Aureus Bacteremia. Clin Infect DIS 2013; 56:527
Crossover was performed after including 15 patients or, at...
- Youngster I, Shenoy Es, Hooper Dc, Nelson Sb. Comparative Evaluation of The Tolerability of Cefazolin and Nafcillin for Treatment of Methicillin-Susceptible Staphylococcus Aureus Infections in The Outpatient Setting. Clin Infect Dis 2014; 59:369
Medline ® Abstract for Reference 51 of 'Clinical approach to...
- Thwaites Ge, Scarborough M, Szubert A, Et Al. Adjunctive Rifampicin for Staphylococcus Aureus Bacteraemia (Arrest): a Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial. Lancet 2018; 391:668
FINDINGS Between Dec 10, 2012, and Oct 25, 2016, 758...
- Vogel M, Schmitz Rp, Hagel S, Et Al. Infectious Disease Consultation for Staphylococcus Aureus Bacteremia - a Systematic Review and Meta-Analysis. J Infect 2016; 72:19
14 PubMed | TI Clinical management of Staphylococcus aureus...
- Rasmussen Rv, Høst U, ARPI M, Et Al. Prevalence of Infective Endocarditis in Patients With Staphylococcus Aureus Bacteraemia: The Value of Screening With Echocardiography. EUR J Echocardiogr 2011; 12:414
Medline ® Abstract for Reference 21 of 'Clinical approach to...
- Mylotte Jm, McDermott C, Spooner Ja. Prospective Study of 114 Consecutive Episodes of Staphylococcus Aureus Bacteremia. Rev Infect DIS 1987; 9:891
{{configCtrl2.info.metaDescription}} This site uses cookies....
- Thomas L Holland, MD
Clinical approach to Staphylococcus aureus bacteremia in...
- Khandheria Bk, Seward Jb, Tajik Aj. Transesophageal Echocardiography. Mayo Clin Proc 1994; 69:856
Twenty-one percent were methicillin-resistant Staphylococcus...
- Forsblom E, Ruotsalainen E, Ollgren J, Järvinen A. Telephone Consultation Cannot Replace Bedside Infectious Disease Consultation in The Management of Staphylococcus Aureus Bacteremia. Clin Infect DIS 2013; 56:527
17 Ιουλ 2023 · These organisms can grow aerobically or anaerobically (facultative) and at temperatures between 18 C and 40 C. Typical biochemical identification tests include catalase positive (all pathogenic Staphylococcus species), coagulase positive (to distinguish Staphylococcus aureus from other Staphylococcus species), novobiocin sensitive (to ...
Staphylococcus aureus infections range from mild to life threatening. The most common staphylococcal infections are. However, the bacteria can travel through the bloodstream (called bacteremia) and infect almost any site in the body, particularly heart valves (endocarditis) and bones (osteomyelitis).
Staphylococcus aureus is a major human pathogen that causes a wide range of clinical infections. It is a leading cause of bacteremia and infective endocarditis as well as osteoarticular, skin and soft tissue, pleuropulmonary, and device-related infections.
Staphylococcus aureus is a major human pathogen that causes a wide range of clinical infections. It is a leading cause of bacteremia and infective endocarditis as well as osteoarticular, skin and soft tissue, pleuropulmonary, and device-related ...
S. aureus also produces catalase; when applied to colony material, the catalase test is a rapid, useful test to distinguish staphylococci from other Gram-positive bacteria such as streptococci. S. aureus is a facultative anaerobe that grows by aerobic respiration or by fermentation, which yields principally lactic acid.
1 Σεπ 2005 · The time to positivity ranged from 4.2 to 98.2 h (median time to positivity, 15.5 h) and was significantly shorter for patients with an endovascular source of infection (14.9 ± 5.4 vs. 19.5 ± 10.6 h; P < .0005), extended duration (i.e., ⩾3 days) of bacteremia (14.1 ± 4.2 vs. 18.6 ± 9.2 h; P < .0005), and metastatic infection (12.9 ± 5.9 ...